Burns Market Expected to Exhibit Dynamic Growth at an Increased CAGR of 1.96% in the 7MM for the Study Period 2018-30, Analyzes DelveInsight
Burns treatment pipeline is indicative of favourable market growth. Key pharma companies like CUTISS AG, Skingenix, and others are developing potential Burns treatment therapies such as DenovoSkin, MW-III, and others, which are anticipated to boost the Burns market.
LAS VEGAS, Nov. 8, 2021 /PRNewswire/ -- DelveInsight's Burns Market Insights report proffers a detailed comprehension of Burns market size by treatment, epidemiology, emerging therapies, Burns market drivers, market barriers, and ongoing clinical trials. The report also provides an understanding of Burns market share of the individual therapies, current and forecasted Burns market size from 2018 to 2030 segmented into 7MM (the US, EU5 (the UK, Italy, Spain, France, and Germany), and Japan).
Some of the major takeaways from the Burns Market Report:
- The Burns market size was USD 830 million in 2020 in the United States. DelveInsight estimates suggest that the United States had the highest incident population of burn injuries that required medical treatment. The market size of Burns is expected to grow at a CAGR of 1.96% in the 7MM for the study period 2018-2030.
- The Burns pipeline therapies include DenovoSkin, CellMist System, MW-III, and others, which may improve the treatment dynamics in the upcoming future.
- Major pharma giants working proactively in the Burns therapeutic market include CUTISS AG, Skingenix, Polynovo, Mallinckrodt Pharmaceuticals, Kerecis, MediWound Germany GmbH, Kaken Pharmaceutical Co., Avita Medical, Vericel Corporation, KeraNetics, Integra Life Sciences Corporation, Medline Industries, Anika Therapeutics, ACell, Amryt Pharma, Skingenix, RenovaCare, and many more.
- The Burns market is expected to be driven by factors such as the increasing incidence, availability of a wide range of treatment options, and advancements in burn care treatments and products.
- The Burns market may be hampered by several factors including stringent regulatory guidelines for the approval of new treatment or medicine and high cost for the treatment.
- A major breakthrough in Burns treatment is a bio-engineered DenovoSkin which is being developed by CUTISS AG.
Download Burns Market sample to understand the comprehensive treatment scenario @ Burns Market Treatment Landscape
Burns: Overview
A Burn takes place when the skin comes into contact with a heat source. Burns can occur from many different sources. The most common sources that cause Burns are fire/flame, scalds, hot objects, electrical, and chemical agents, respectively. Burns is a common injury seen in emergency departments around the world. Even as emergency management improves, Burns continues to have significant morbidity and mortality.
Request for a Webex demo of the report @ Burns Market Report
Burns Epidemiology Segmentation
DelveInsight's analysis indicates that the majority of Burns injury cases taking treatment are males due to most Burn cases occurring at the workplace making males more vulnerable to Burns. There were 411,066 male and 251,944 female cases of treated burn injuries in 2020 in the United States.
In the same year, the Burns severity-specific estimated cases were observed to be 144,536, 387,198, 19,890, and 111,386 for first-degree, second-degree, third-degree, and unspecified, respectively in the United States.
The Burns Market Report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
- Incident Cases of Burns Patient Requiring Treatment
- Gender-specific Incident Cases of Treated Burn Injuries
- Etiology-specific Incident Cases of Treated Burn Injuries
- Severity-specific Incident Cases of Treated Burn Injuries
- Incident Cases of Hospitalized Burns Patients
Know how Burns Epidemiological Trends are going to look like in 2030 for the 7 MM by downloading @ Burns Epidemiological Insights
In the current market scenario, the standard treatment for Burns involves medications, wound dressings, therapy, and surgery. The Burns treatment goal is to control pain, remove dead tissue, prevent infection, reduce scarring risk, and regain function. The Burns treatment depends on the severity of the burn. Currently, some major pharmaceutical companies like Kerecis, Polynovo, Mallinckrodt, are marketing Burns treatment therapies like Kerecis Omega3, NovoSorb BMT, and Stratagraft.
Despite the widespread availability of safe and effective Burns medications and surgery options, pharmaceuticals like Cutiss AG, Skingenix, and many more are developing novel Burns treatment therapies. One major breakthrough therapeutic product DenovoSkin is being developed by CUTISS AG which is bio-engineered with a thick, double layer, robust structure. DenovoSkin is a patented, personalized, autologous bio-engineered human skin graft classified as Advanced Therapy Medical Product (ATMP). DenovoSkin has successfully completed Phase I. Another therapeutic product is MW-III, by Skingenix, which is a topical product being evaluated for second-degree burns in adult patients.
To know about more pipeline therapies under different development phases visit @ Burns Pipeline Assessment
The rise in the number of incident Burn cases can be considered as a prominent factor for Burns market surge in the coming years. The Burns market is expected to show positive growth, mainly attributed to factors like increase in research and development activities, rise in the number of clinical studies, increasing number of surgical procedures, the launch of upcoming therapies, and the availability of a wider range of treatment options.
However, unreported and undiagnosed Burns cases and the absence of effective treatment are some of the major blockades in the Burns market growth. Apart from that, stringent regulatory guidelines are also applied for the approval of new treatment with the high cost for the treatment of Burns which may act as setbacks.
Browse a complete Burns Market report @ Burn Market Landscape and Forecast
Scope of the Burns Market Report
- Study Period: 2018-30
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.]
- Key Companies: Mallinckrodt Pharmaceuticals, Polynovo, Kerecis, CUTISS AG, Skingenix, MediWound Germany GmbH, Kaken Pharmaceutical Co., Avita Medical, Vericel Corporation, KeraNetics, Integra Life Sciences Corporation, Medline Industries, Anika Therapeutics, ACell, Amryt Pharma, Skingenix, RenovaCare, and many more
- Key Burns Pipeline Therapies: DenovoSkin, CellMist System, MW-III, and others
- Therapeutic Assessment: Burns current marketed and emerging therapies
- Market Dynamics: Burns market drivers and barriers
- Competitive Intelligence Analysis: PEST Analysis
- Unmet Needs
- KOL's views
- Analyst's views
- Market Access and Reimbursement
Discover more about the future market share of Burns treatment therapies @ Burns Market Forecast Outlook
Table of Contents
1 |
Key Insights |
2 |
Burns Report Introduction |
3 |
Burns Market overview at a glance |
4 |
Disease Background and Overview: Burns |
5 |
Burns Epidemiology and Patient Population (7MM) |
6 |
Burns: Country Wise-Epidemiology |
7 |
Treatments & Medical Practices in Burns |
8 |
Current Treatment in Burns |
9 |
Burns Emerging Treatment |
10 |
Burns Competitive Analysis |
11 |
Burns: Seven Major Market Analysis |
12 |
7MM: Burns Country-wise Market Analysis |
13 |
Burns United States Market Size |
14 |
Burns EU5 Market Size |
15 |
Burns Japan Market Size |
16 |
Burns Market Drivers |
17 |
Burns Market Barriers |
18 |
Report Methodology |
19 |
DelveInsight Capabilities |
20 |
Disclaimer |
21 |
About DelveInsight |
Get in touch with our Business executive @ Burns Market Landscape Analysis
Related Reports
DelveInsight's, "Burns - Pipeline Insight, 2021," report offers rich insights into epidemiology, treatments, pipeline therapies, and key companies including NeoMatrix Therapeutic, Amniotics, Alloksys Life Sciences, Medline Industries, Skingenix, Inc., Anterogen, Noveome Biotherapeutics, Phagelux Inc., Bioharmony Therapeutics, Amarantus Bioscience, and several others.
DelveInsight's, "Celiac Disease – Pipeline Insight, 2021," report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Celiac Disease pipeline landscape such as Takeda, Amgen, ImmusanT, Janssen Research & Development, LLC, Kanyos Bio, Calypso Biotech, Protagonist Therapeutics, ActoBio Therapeutics, Bioniz Therapeutics, Allero Therapeutics, and others.
DelveInsight's 'Ascites-Market Insights, Epidemiology, and Market Forecast–2030' report delivers an in-depth understanding of the Ascites, historical and forecasted epidemiology, market drivers, market barriers, SWOT analysis, and key companies involved such as BioVie, Noorik Biopharmaceuticals AG, and several others.
Skin Grafting Devices - Market
DelveInsight's 'Skin Grafting Devices - Market Insights, Competitive Landscape and Market Forecast–2026' report delivers an in-depth understanding of Skin Grafting Devices and the historical and forecasted Skin Grafting Devices market trends in the US, EU5, Japan, market drivers, market barriers and key companies involved like Zimmer Inc, Aesculap, Inc, B. Braun Company, Exsurco Medical, PFM Medical, Rudolf Storz, AYGUN Surgical Instruments Co. Inc, Desoutter Medical, LUTZ blades, Spiggle & Theis, and many more.
DelveInsight's 'Dermatoscopes Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of Dermatoscopes and the historical and forecasted Dermatoscopes market trends, market drivers, market barriers and key companies involved like Canfield Scientific, Inc, 3Gen, FotoFinder Systems, Inc, Optilia, HEINE Optotechnik GmbH & Co. KG, Caliber Imaging & Diagnostics, Inc, Firefly Global, ILLUCO Corporation Ltd, Welch Allyn, Bio-Therapeutic, and many more.
DelveInsight's 'Skin Burns - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Skin Burns epidemiology in the 7MM.
Deep Partial-Thickness Thermal Burns Pipeline
"Deep Partial-Thickness Thermal Burns Pipeline Insights, 2021" report by DelveInsight offers rich insights into current and emerging treatments, pipeline therapies, and key pharmaceuticals contributing to the development of Deep Partial-Thickness Thermal Burns Pipeline.
Adrenocortical Carcinoma Market
DelveInsight's "Adrenocortical Carcinoma - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Adrenocortical Carcinoma, historical and forecasted epidemiology as well as market, epidemiology, pipeline therapies, and key companies involved.
DelveInsight's 'Alagille Syndrome (ALGS) – Market Insights, Epidemiology, and Market Forecast—2030' report proffer detailed analysis of epidemiology, treatments, pipeline therapies, and key companies including Mirum Pharmaceuticals, Albireo, and many others.
Browse through our Blog Posts
Cancer today is one of the most deadly diseases worldwide, causing a significant burden in terms of mortality, years of life lost, and disability as compared to other diseases.
The necessity of a robust Angelman syndrome pipeline is indispensable at the current moment because of a shortage of any approved therapy option available in the market.
The contribution of key pharma companies, such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Cour Pharmaceuticals/Takeda, Precigen ActoBio, Falk Pharma, and Zedira is significant in driving Celiac disease market size.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Connect With Us at LinkedIn | Facebook | Twitter
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com
Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
Share this article